Why Treat Apogeotropic BPPVs of the Horizontal Canal? About 30 Observations

Table 2

Summarizes our statistical study and the Fischer test.

	Average age	Average positional risk	Average scarring time	Average number of consultations before recovery	Average time to consultation	Average VSS and DHI scores	Average videoscopic score
Young subjects	46	15.08	10.27	1.6	10.4	42.67	3.6
Older subjects	71.2	16.02	11.27	2.4	12.8	43.87	4
Small 𝑃	0	0.307	0.76	0.002	0.05	0.918	0.892
Transformable AHBPPVs	56	15.42	8.25	1.88	9.81	40.13	3.52
Non-transformable AHBPPVs	61.2	15.68	13.29	2.12	13.39	46.41	4.09
Small 𝑃	0.375	0.307	0.101	0.333	0.346	0.563	0.547
Low positional risk	59.4	13.44	8.4	1.87	10.53	44.8	4.53
High positional risk	57.8	17.66	13.13	2.13	12.67	41.73	3.07
Small 𝑃	0.779	0	0.152	0.334	0.601	0.792	0.701
Short scarring time	56.2	14.8	3.87	1.93	11.3	38.67	4.26
Long scarring time	61	16.3	17.67	2.07	11.9	47.87	3.34
Small 𝑃	0.397	0.193	0	0.631	0.819	0.428	0.482
Low number of consultation	57.2	15	9.2	1.53	10.4	44.67	2.8
High number of consultation	60	16.1	12.33	2.47	12.8	41.87	4.8
Small 𝑃	0.623	0.307	0.348	0	0.556	0.81	0.04
Short time to consultation	57.6	15.73	11	1.57	3.73	39.73	4.27
Long time to consultation	59.6	15.37	10.53	2.43	19.47	46.8	3.33
Small 𝑃	0.326	0.636	0.89	0.032	0	0.543	0.603